PT-141 (Bremelanotide) 10mg
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and melanocortin receptor agonist, acting primarily on MC3R and MC4R receptors in the central nervous system. It was developed from Melanotan II and represents a distinct mechanism for sexual function research — CNS-mediated rather than vascular.
Research has characterized PT-141's dose-dependent effects on sexual arousal and behavior in rodent and primate models, operating through hypothalamic pathways rather than direct vascular mechanisms. It is FDA-approved for hypoactive sexual desire disorder (as Vyleesi) in women, providing a well-characterized research foundation.
Specifications: 10mg lyophilized powder | Purity ≥99% (HPLC) | MW 1025.2 g/mol | Store at −20°C
For Research Use Only. Not for human or veterinary use. This product is intended solely for in vitro and laboratory research. Not approved by the FDA. Not a drug, food, or cosmetic. Keep out of reach of children.
